Trial intelligence / Profile preview

Antibiotic or Inhaled Corticosteroid vs Placebo in Children's Protracted Cough

2025-520697-19-00Phase 3Authorised

Sponsor
Pirkanmaan hyvinvointialue
Start
Jun 2025
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in chronic cough comparing Amorion Comp, Flixotide Evohaler and Placebo (3 arms). Primary endpoint: Clinically significant reduction in cough. Planned start Jun 2025; status: authorised.

02

Drugs

Flixocortamoxicillin + clavulanic acid
03

Conditions

chronic cough

Beyond the preview

Go deeper on 2025-520697-19-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2025-520697-19-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call